Minorities most vulnerable to financial slide after breast cancer

Key points
- Black and Latina breast cancer patients were more than twice as likely as white women to have lingering medical debt and to skip treatments because of costs, according to a new U.S. study.
- Based on surveys of 1,500 women diagnosed with mostly early-stage breast cancers, researchers found that up to one quarter were struggling financially as a result of their disease.
- "Although we were able to control for factors such as overall household income in this study, it is likely that other disparities and challenges faced by minority populations persist in our society even today, contributing to the differences observed," author Dr.
- Jagsi worked on the study in the Department of Radiation Oncology at the University of Michigan in Ann Arbor.
Black and Latina breast cancer patients were more than twice as likely as white women to have lingering medical debt and to skip treatments because of costs, according to a new U.S. study.
Based on surveys of 1,500 women diagnosed with mostly early-stage breast cancers, researchers found that up to one quarter were struggling financially as a result of their disease.
"Although we were able to control for factors such as overall household income in this study, it is likely that other disparities and challenges faced by minority populations persist in our society even today, contributing to the differences observed," author Dr. Reshma Jagsi told Reuters Health by email.
Jagsi worked on the study in the Department of Radiation Oncology at the University of Michigan in Ann Arbor.
Between 2005 and 2007, she and her coauthors surveyed women diagnosed with mostly early-stage breast cancers that had not spread nine months after diagnosis and four years later. The women lived in the Los Angeles and Detroit areas and about half had received chemotherapy.
Of those women, 12 percent reported having medical debt at the four-year survey.
That group included nine percent of the white women participating in the survey, compared to 10 percent of the Spanish-speaking Latinas, 17 percent of the English-speaking Latinas and 15 percent of the black women, according to the results in the Journal of Clinical Oncology.
These proportions persisted even when the researchers accounted for income, education and employment.
About 35 percent of the women reported spending $2,000 or more out-of-pocket on cancer treatments, and 17 percent spent more than $5,000.
At the four-year mark, some survey questions assessed the level of financial strain the women had been under for the past year.
Six percent of black women, compared to 3 percent of white women, said they had taken less than the full amount of their prescribed medications in the last year due to cost. Black and Latina women were also more likely to have missed doctor appointments due to cost than white women.
Black and Latina women were more likely to have gone without health insurance or moved out of their houses due to cost since their cancer diagnosis, although only five percent of women total had to do this.
Two percent of white women reported having utilities turned off due to unpaid bills, compared to 11 percent of black women.
"Overall, cancer is one of the most expensive diseases to treat in the United States," Dr. S. Yousuf Zafar told Reuters Health by email.
Zafar, a medical oncologist at Duke Cancer Center in Durham, North Carolina, was not involved in the new study.
"Compared to patients with chronic illnesses other than cancer, patients with cancer are at risk for higher treatment-related out-of-pocket expenses," he said.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsUGR scientists patent an effective drug for treating breast, colon, and skin cancers
Scientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in breast, colon, and skin cancers. The researchers have proved the anti-tumor effects of the drug on…
21 October 2015
GuideDecoding the microbial signature of aggressive form of breast cancer
Cancer is a result of normal cellular functions going wildly awry on a genetic level. That fact has been known for some time, but increasing evidence is showing that the human microbiome, the diverse population of…
16 October 2015
NewsAdoption of streamlined breast cancer treatment has stagnated, study finds
Accelerated partial breast irradiation was designed to be a faster, more convenient, and potentially safer way for many women with breast cancer to reduce their mortality risk and help keep their cancer from returning…



